Trial NCT03379259

View at ClinicalTrials.gov 
Org. Study IDs: BGB-900-101
Secondary IDs: 2018-000265-37

Last trial update was posted on 2021-11-09

MeSH Interventions

Tislelizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumors

Stopping Reasons

Study Was Terminated Early

Limitations And Caveats

Phase 2A of the study was not initiated nor conducted since BGB-A333 as a monotherapy treatment beyond the completion of dose escalation in Phase 1A was not pursued.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID